M. Garcia-Barchino

发表

Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.

H. Rui, L. Schuler, L. Arendt, 2009, The Journal of endocrinology.

Richter transformation driven by Epstein–Barr virus reactivation during therapy‐related immunosuppression in chronic lymphocytic leukaemia

Antonio Martínez, J. Martinez-Climent, F. Prósper, 2018, The Journal of pathology.

LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative Neoplasms.

M. García-Delgado, F. J. Novo, J. Vizmanos, 2011, Genes & cancer.

Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.

J. Martinez-Climent, F. Prósper, X. Agirre, 2018, Journal of medicinal chemistry.

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.

J. Martinez-Climent, Karen L. Bunting, A. Melnick, 2019, Blood.

NH2-terminal Truncated HER-2 Protein but not Full-Length Receptor Is Associated with Nodal Metastasis in Human Breast Cancer

J. Garcia-conde, J. Baselga, F. Rojo, 2002 .

NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer.

J. Garcia-conde, J. Baselga, F. Rojo, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

M. Monje, J. Martinez-Climent, M. Junier, 2019, Nature Communications.

Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase‐2 transgene

M. Díaz-Guerra, L. Boscá, S. Hortelano, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death.

M. Moreno-Aliaga, Jiahuai Han, J. Martinez-Climent, 2020, Cancer discovery.

Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.

J. Martinez-Climent, D. Blesa, J. Climent, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma

J. Martinez-Climent, F. Prósper, N. Puig, 2022, Science advances.

Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.

J. Martinez-Climent, V. Fresquet, C. Carolis, 2014, Blood.

Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms

J. Martinez-Climent, J. Prieto, O. Rabal, 2017, Haematologica.

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer

H. Rui, L. Schuler, L. Arendt, 2011, Breast Cancer Research.

Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies

J. Martinez-Climent, F. Prósper, J. Martín-Subero, 2017, Nature Communications.

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

J. San Miguel, J. Martinez-Climent, F. Prósper, 2023, Nature Medicine.

Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling

R. Bernards, J. Martinez-Climent, M. Fornerod, 2016, Oncotarget.

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

M. Monje, J. Martinez-Climent, M. Junier, 2019, Nature Communications.